The EU Scientific Committee on Consumer Safety (SCCS) has concluded that three prostaglandin analogues used in eyelash and eyebrow growth products are not safe at the proposed conc
The EU framework for placing cosmetics on the Union market centres on Regulation (EC) No 1223/2009 — Responsible Person, CPNP, safety file, labeling, and annex-driven ingredient rules.
The August desk: China rewrote the standard stack and the filing portal; the EU allergen placing date landed; Illinois joined the US state grid.
A “new INCI” is not one global project. China wants No. 59. The EU wants an annex path or a documented history. The US wants safety substantiation and a listing that matches the label.
2023/1545 is a labeling expansion with 2026/2028 dates. It is not a same-day ban on perfume.
From 31 July 2026, new EU placements must disclose the expanded Annex III fragrance allergens. Existing stock can sell through to 31 July 2028.
Five things that actually moved a calendar in Q2: SCCS triage, China method packs, mercury date approaching, FDA Voices, leftover MoCRA rules.
31 July 2026 is a placing-on-the-market date. 31 July 2028 is making-available. Warehouse logic has to know the difference.
A 30-minute read: who asked, is it in force, what date is real, what SKUs match, what you tell sales today.
An SCCS opinion is scientific advice to the Commission. It is not an annex amendment. Triage: listed in CosIng annex already, or still only an opinion?